Artificial Intelligence

From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Exploring Artificial Intelligence in Drug Discovery

AI is cutting drug development timelines in half while helping biotech companies identify viable compounds faster and more accurately than traditional methods

Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation

Smaller pharma companies are accelerating drug development by leveraging advanced data analytics to streamline trials and regulatory pathways

A New Dawn in Medicine: The Intersection of AI and Value-Based Care Could Reduce Costs, Increase Access

Artificial intelligence combined with value-based care models is reshaping how providers deliver treatment while simultaneously lowering expenses and expanding

In the Face of Healthcare Challenges, Effective Leadership Makes the Difference

Medical leaders are discovering that navigating industry upheaval requires vision and adaptability beyond clinical expertise

President Biden’s AI Executive Order is an Imperfect but Needed First Step for Future AI Development

The nation's inaugural AI regulation framework establishes critical safety guardrails while leaving room for industry innovation and future refinement